Related Experiment Video

Updated: May 17, 2026

Isolation of Small Noncoding RNAs from Human Serum
06:44

Isolation of Small Noncoding RNAs from Human Serum

Published on: June 19, 2014

Serum microRNA expression profile as a biomarker for the diagnosis of pertussis

Yiyue Ge1, Kangchen Zhao, Yuhua Qi

  • 1Institute of Pathogen Microbiology, Jiangsu Provincial Center for Disease Prevention and Control, Key Laboratories of Enteric Pathogenic Microbiology, Ministry of Health, Nanjing, 210009, China.

Molecular Biology Reports
|October 18, 2012
PubMed

Insights

A new study identifies a five-microRNA (miRNA) signature in blood that accurately diagnoses pertussis (whooping cough). This non-invasive biomarker panel shows high sensitivity and specificity for detecting the contagious respiratory disease.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biomarker Discovery

Background:

  • Pertussis (whooping cough) is a highly contagious respiratory illness causing significant illness and death.
  • Current diagnostic methods for pertussis may lack speed and reliability, hindering timely treatment and control.
  • Circulating microRNAs (miRNAs) are emerging as promising non-invasive biomarkers for infectious diseases.

Purpose of the Study:

  • To investigate serum miRNA expression profiles in pertussis patients.
  • To explore the potential of these miRNA profiles as novel diagnostic biomarkers for pertussis.
  • To identify a specific miRNA signature for accurate pertussis diagnosis.

Main Methods:

  • Serum samples from pertussis patients and controls were analyzed using miRNA arrays to identify differentially expressed miRNAs.
  • Expression levels of candidate miRNAs were validated using real-time quantitative reverse transcription PCR (qRT-PCR).
  • A panel of five miRNAs was identified and evaluated using risk score and receiver-operating characteristic (ROC) analysis.

Main Results:

  • Analysis of 664 miRNAs revealed significant overexpression and underexpression in pertussis patients.
  • A panel of five specific miRNAs (miR-202, miR-342-5p, miR-206, miR-487b, miR-576-5p) was confirmed to be overexpressed (p < 0.05).
  • The five-miRNA panel achieved an area under the ROC curve of 0.980, with 97.4% sensitivity and 94.3% specificity at an optimal cutoff.

Conclusions:

  • The identified five-member serum miRNA profile demonstrates high diagnostic accuracy for pertussis.
  • This miRNA panel represents a potential novel, non-invasive biomarker for the rapid diagnosis of pertussis.
  • Further validation could lead to improved clinical management and public health strategies for pertussis control.

More Related Videos

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening

Published on: October 26, 2017

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform10:37

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

Published on: November 30, 2016

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...